Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio as Prognostic Predictors for Hepatocellular Carcinoma Patients with Various Treatments: a Meta-Analysis and Systematic Review | Zendy

Jun Zheng | Zendy; Jianye Cai | Zendy; Hui Li | Zendy; Kaining Zeng | Zendy; Liying He | Zendy; Hongyuan Fu | Zendy; Jiebin Zhang | Zendy; Liang Chen | Zendy; Jia Yao | Zendy; Yingcai Zhang | Zendy; Yang� Yang | Zendy

Open Access

Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio as Prognostic Predictors for Hepatocellular Carcinoma Patients with Various Treatments: a Meta-Analysis and Systematic Review

Author(s) -

Jun Zheng,

Jianye Cai,

Hui Li,

Kaining Zeng,

Liying He,

Hongyuan Fu,

Jiebin Zhang,

Liang Chen,

Jia Yao,

Yingcai Zhang,

Yang� Yang

Publication year - 2017

Publication title -

cellular physiology and biochemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.486

H-Index - 87

eISSN - 1421-9778

pISSN - 1015-8987

DOI - 10.1159/000485396

Subject(s) - medicine , hepatocellular carcinoma , hazard ratio , neutrophil to lymphocyte ratio , confidence interval , meta analysis , gastroenterology , subgroup analysis , lymphocyte , oncology

Systemic inflammatory response (SIR) is widely considered as a preoperative risk factor for hepatocellular carcinoma (HCC) outcomes. The neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR), two of the prognostic indices, have been investigated in post-therapeutic recurrence and survival of HCC. Here, we quantify the prognostic value of these two biomarkers and evaluate their consistency in different HCC therapies.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research